Cargando…
Weak acid-initiated slow release of Dexamethasone from hydrogel to treat orbital inflammation
Rationale: Orbital inflammation is a prevalent and prolonged ocular disease that poses a significant challenge to clinicians. Glucocorticoid Dexamethasone sodium phosphate (Dex) has demonstrated efficacy in the clinical treatment of nonspecific orbital inflammation. However, frequent administration...
Autores principales: | Li, Jinjing, Zhang, Aichi, Zhao, Andi, Chen, Zhaoxia, Liang, Gaolin, Liu, Hu, Wu, Chengfan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405854/ https://www.ncbi.nlm.nih.gov/pubmed/37554273 http://dx.doi.org/10.7150/thno.85627 |
Ejemplares similares
-
Infographic: Slow-release dexamethasone in proliferative vitreoretinopathy (PVR)
por: Mostafa, I., et al.
Publicado: (2021) -
An Injectable Click-Crosslinked Hydrogel that Prolongs Dexamethasone Release from Dexamethasone-Loaded Microspheres
por: Heo, Ji Yeon, et al.
Publicado: (2019) -
Self-Healing
Thermosensitive Hydrogel for Sustained
Release of Dexamethasone for Ocular Therapy
por: Annala, Ada, et al.
Publicado: (2022) -
Orbits in weak and strong bars
por: Contopoulos, George, et al.
Publicado: (1980) -
Primary adenocarcinoma of the orbit initially diagnosed as idiopathic sclerosing orbital inflammation
por: Reed, Donovan, et al.
Publicado: (2019)